The data revealed that the exhaustion status of CD8+ T cells was significantly improved in MPR tumor lesions, with reduced expression of exhausted markers, such as PDCD1, CTLA4, LAG3, and TIGIT. This evidence concerns the gene CD8A and neoplasm.